Clinical Pharmacology & Therapeutics

TABLE 2

FROM:

Dose–Response of Ritonavir on Hepatic CYP3A Activity and Elvitegravir Oral Exposure

AA Mathias, S West, J Hui and BP Kearney

BACK TO ARTICLE

Table 2. Mean (%CV) pharmacokinetic (PK) parameters for midazolam

Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author
BACK TO ARTICLE